Viewing Study NCT03723135


Ignite Creation Date: 2025-12-24 @ 10:09 PM
Ignite Modification Date: 2026-02-20 @ 10:09 PM
Study NCT ID: NCT03723135
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2020-09-18
First Post: 2018-10-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access for CC-486
Sponsor: Celgene
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myelogenous Leukemia (AML) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Expanded Access View
None Compassionate Use View